TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

Trader New York Stock Exchange Lead
Play
JIM CRAMER

All the Right Moves: Cramer's 'Mad Money' Recap (Tuesday 1/14/20)

  • By Scott Rutt
  • Jan 14, 2020 8:38 PM EST
PRESS RELEASES

Revance To Participate In The 39th Annual J.P. Morgan Healthcare Conference

  • By Business Wire
  • Jan 7, 2021 4:05 PM EST
PRESS RELEASES

Revance Provides Corporate Update And Anticipated Milestones For 2021

  • By Business Wire
  • Jan 7, 2021 8:00 AM EST
PRESS RELEASES

Ajinomoto Bio-Pharma Services And Revance Therapeutics Announce Manufacturing Agreement For Supply Of DaxibotulinumtoxinA For Injection

  • By PR Newswire
  • Dec 22, 2020 8:00 AM EST
PRESS RELEASES

Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

  • By Business Wire
  • Dec 21, 2020 4:05 PM EST
PRESS RELEASES

Nashville Skyline (Photo: Business Wire)

  • By Business Wire
  • Dec 16, 2020 8:30 AM EST
PRESS RELEASES

FDA Defers Approval Of DaxibotulinumtoxinA For Injection In Glabellar Lines Due To COVID-19 Related Travel Restrictions Impacting Manufacturing Site Inspection

  • By Business Wire
  • Nov 25, 2020 8:30 AM EST
PRESS RELEASES

Revance To Participate In The Piper Sandler 32nd Annual Virtual Healthcare Conference

  • By Business Wire
  • Nov 24, 2020 4:05 PM EST
PRESS RELEASES

Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

  • By Business Wire
  • Nov 20, 2020 4:05 PM EST
PRESS RELEASES

Revance To Participate In The Stifel 2020 Virtual Healthcare Conference

  • By Business Wire
  • Nov 10, 2020 4:05 PM EST
PRESS RELEASES

Revance Announces Results Of Phase 2 Trial Of DaxibotulinumtoxinA For Injection In Plantar Fasciitis

  • By Business Wire
  • Nov 9, 2020 4:05 PM EST
PRESS RELEASES

Revance To Participate In The Credit Suisse 29th Annual Healthcare Conference

  • By Business Wire
  • Nov 3, 2020 4:05 PM EST
PRESS RELEASES

Revance To Release Third Quarter 2020 Financial Results On Monday, November 9, 2020

  • By Business Wire
  • Nov 2, 2020 4:05 PM EST
PRESS RELEASES

Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

  • By Business Wire
  • Oct 23, 2020 4:05 PM EDT
PRESS RELEASES

Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

  • By Business Wire
  • Sep 23, 2020 4:05 PM EDT
PRESS RELEASES

Revance To Participate In The Morgan Stanley 18th Annual Global Healthcare Conference

  • By Business Wire
  • Sep 8, 2020 4:05 PM EDT
PRESS RELEASES

Revance To Participate In The Wells Fargo Securities Healthcare Conference

  • By Business Wire
  • Sep 2, 2020 8:00 AM EDT
PRESS RELEASES

Revance Commercial Infrastructure Established And Positioned To Launch Prestige Aesthetics Portfolio With The RHA® Collection Of Dermal Fillers

  • By Business Wire
  • Aug 25, 2020 8:00 AM EDT
PRESS RELEASES

Revance Announces Two Peer-Reviewed Publications Reporting Safety And Efficacy Results From The SAKURA 3 Open-Label Safety Study In Dermatologic Surgery

  • By Business Wire
  • Aug 11, 2020 8:30 AM EDT
PRESS RELEASES

Revance To Release Second Quarter 2020 Financial Results On Thursday, August 6, 2020

  • By Business Wire
  • Jul 30, 2020 4:05 PM EDT
PRESS RELEASES

Revance Completes Previously Announced Acquisition Of HintMD And Its Proprietary Fintech Platform For Aesthetic Practices

  • By Business Wire
  • Jul 23, 2020 6:20 PM EDT
PRESS RELEASES

Revance Announces Last Patient Enrolled In Modified JUNIPER Phase 2 Upper Limb Spasticity Trial Of DaxibotulinumtoxinA For Injection

  • By Business Wire
  • Jun 30, 2020 4:05 PM EDT
PRESS RELEASES

Revance To Participate In The 40th Annual William Blair Growth Stock Conference

  • By Business Wire
  • Jun 4, 2020 4:05 PM EDT
PRESS RELEASES

Revance To Present At The Goldman Sachs 41st Annual Global Healthcare Conference Webcast

  • By Business Wire
  • Jun 2, 2020 4:05 PM EDT
PRESS RELEASES

Revance And Mylan To Advance Development Program For Biosimilar To BOTOX®

  • By Business Wire
  • Jun 1, 2020 8:30 AM EDT
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.